Enhancing TFAM: Human mitochondrial transcription factor A (hTFAM) activation was shown to protect mtDNA, reduce oxidative damage and intracellular Aβ, and improve cognitive function in both mouse and human AD models, making it a promising therapeutic target [181]. Here, TFAM is linked to Alzheimer disease.